Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility
作者:Lanqi Jia、Robert D. Simpson、Jing Yuan、Zhenrong Xu、Wei Zhao、Salvacion Cacatian、Colin M. Tice、Joan Guo、Alexey Ishchenko、Suresh B. Singh、Zhongren Wu、Brian M. McKeever、Yuri Bukhtiyarov、Judith A. Johnson、Christopher P. Doe、Richard K. Harrison、Gerard M. McGeehan、Lawrence W. Dillard、John J. Baldwin、David A. Claremon
DOI:10.1021/ml200137x
日期:2011.10.13
Structure guided optimization of a series of nonpeptidic alkyl amine renin inhibitors allowed the rational incorporation of additional polar functionality. Replacement of the c-yclohexylmethyl group occupying the SI pocket with a (R)-(tetrahydropyran-3-yl)methyl group and utilization of a different attachment point led to the identification of clinical candidate 9. This compound demonstrated excellent selectivity over related and unrelated off-targets, >15% oral bioavailability in three species, oral efficacy in a double transgenic rat model of hypertension, and good exposure in humans.